Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioceres Semillas is the seed-focused subsidiary of Bioceres Crop Solutions, a global leader in agricultural biotechnology. The company specializes in developing and commercializing high-impact crop traits, most notably the HB4 technology which confers drought and salinity tolerance to wheat and soybeans. By integrating advanced genetics with biological crop protection and nutrition, Bioceres provides a comprehensive "Eco-Seed" platform designed to improve farming productivity while reducing environmental impact. The company made history by receiving the world's first regulatory approvals for drought-tolerant transgenic wheat, positioning itself as a key player in climate-resilient agriculture. Headquartered in Argentina, Bioceres Semillas leverages a robust R&D pipeline and strategic partnerships to expand its footprint across major global agricultural markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioceres Semillas.